Rani Therapeutics Holdings, Inc.
RANI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $39,012 | $84,677 | $140,520 | $322,291 |
| - Cash | $3,762 | $5,864 | $27,007 | $117,453 |
| + Debt | $29,709 | $30,099 | $30,214 | $0 |
| Enterprise Value | $64,959 | $108,912 | $143,727 | $204,838 |
| Revenue | $1,028 | $0 | $0 | $2,717 |
| % Growth | – | – | -100% | – |
| Gross Profit | $1,028 | -$822 | $0 | $2,717 |
| % Margin | 100% | – | – | 100% |
| EBITDA | -$50,523 | -$65,277 | -$61,655 | -$52,084 |
| % Margin | -4,914.7% | – | – | -1,917% |
| Net Income | -$30,018 | -$33,970 | -$30,588 | -$8,331 |
| % Margin | -2,920% | – | – | -306.6% |
| EPS Diluted | -1.05 | -1.33 | -1.28 | -0.42 |
| % Growth | 21.1% | -3.9% | -204.8% | – |
| Operating Cash Flow | -$35,496 | -$51,236 | -$46,515 | -$32,245 |
| Capital Expenditures | -$268 | -$1,229 | -$1,619 | -$506 |
| Free Cash Flow | -$35,764 | -$52,465 | -$48,134 | -$32,751 |